However, it is associated with more modest weight loss than IER: around 3% in the short term and 1% in the long term
Review of clinical trial data on Ozempic and hair loss Clinical data shows that about 0.80% of patients reported telogen effluvium or non-scarring hair loss within six months after starting Semaglutide at 0.25-2mg weekly doses [7]
Last Published 05.01.2026 Effective Date: 05.01.2026 This policy addresses the use of Qalsody (tofersen) for the treatment of amyotrophic lateral sclerosis (ALS)
These medications also have potential serious side effects, like pancreatitis, gallbladder issues, and thyroid tumors, so any history of these conditions is a direct contraindication for prescribing, says Dr
They might also require that you've tried and failed with other weight loss methods
doi:10.1172/jci.insight.140532 28